Clinical Trials Browser

Phase 1 × Neuroendocrine Tumors × surufatinib × Clear all

NCT02267967 2018-11-13

Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors

Phase 1 Completed

Neuroendocrine Tumors